MARKET

LNDC

LNDC

Landec
NASDAQ

Real-time Quotes | Nasdaq Last Sale

10.77
-0.20
-1.82%
Closed 16:00 01/27 EST
OPEN
10.78
PREV CLOSE
10.97
HIGH
10.94
LOW
10.55
VOLUME
110.60K
TURNOVER
--
52 WEEK HIGH
12.24
52 WEEK LOW
7.48
MARKET CAP
315.81M
P/E (TTM)
-5.8555
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
8-K: LANDEC CORP \CA\
(EDGAR Online via COMTEX) -- FALSE000100528600010052862020-06-012020-08-30 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K...
Edgar Online - (EDK = 8-Ks/S1/S-4) · 01/21 05:23
Insider Trends: Landec Insider 90-Day Buying Trend Continued with Purchase
MT Newswires · 01/19 18:02
Landec Appoints New CFO
Landec Appoints New Chief Financial Officer SANTA MARIA, Calif., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Landec Corporation (NASDAQ:LNDC), a diversified health and wellness company with two operating businesses, Curation
Benzinga · 01/19 13:06
Landec Appoints New Chief Financial Officer
Landec Corporation (Nasdaq: LNDC), a diversified health and wellness company with two operating businesses, Curation Foods, Inc. and Lifecore Biomedical, Inc., today announced the appointment of John D. Morberg as Chief Financial Officer, effective January...
GlobeNewswire · 01/19 13:04
*DJ Landec: Morberg Succeeds Brian McLaughlin Who Has Retired >LNDC
Dow Jones · 01/19 13:03
*DJ Landec Names John D. Morberg as Chief Fincl Officer, Effective Jan 18 >LNDC
Dow Jones · 01/19 13:02
Press Release: Landec Appoints New Chief Financial Officer
Dow Jones · 01/19 13:00
*DJ Landec Appoints New Chief Fincl Officer >LNDC
Dow Jones · 01/19 13:00
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of LNDC. Analyze the recent business situations of Landec through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 5 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average LNDC stock price target is 15.00 with a high estimate of 17.00 and a low estimate of 13.00.
EPS
Institutional Holdings
Institutions: 143
Institutional Holdings: 28.26M
% Owned: 96.39%
Shares Outstanding: 29.32M
TypeInstitutionsShares
Increased
26
1.64M
New
23
536.49K
Decreased
41
1.61M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Food Processing
-0.79%
Food & Tobacco
-1.07%
Key Executives
Chairman/Independent Director
Craig Barbarosh
President/Chief Executive Officer/Director
Albert Bolles
Chief Financial Officer/Secretary
John Morberg
Chief Human Resource Officer/Senior Vice President
Dawn Kimball
Senior Vice President
Tim Burgess
Senior Vice President
Timothy Burgess
Vice President
James Hall
Director
Jeffrey Edwards
Director
Joshua Schechter
Director
Patrick Walsh
Independent Director
Deborah Carosella
Independent Director
Katrina Houde
Independent Director
Charles Macaluso
Independent Director
Nelson Obus
Independent Director
Tonia Pankopf
Independent Director
Andrew Powell
Independent Director
Catherine Sohn
  • Dividends
  • Splits
  • Insider Activity
No Data
About LNDC
Landec Corporation designs, develops, manufactures and sells a range of health and wellness products for food and biomaterials markets. The Company licenses technology applications to partners. The Company operates through three segments: Packaged Fresh Vegetables, Food Export and Biomaterials. The Packaged Fresh Vegetables segment markets and packs specialty packaged whole and fresh-cut fruit and vegetables, the majority of which incorporate the BreatheWay specialty packaging for the retail grocery, club store and food services industry. The Food Export segment is engaged in the purchase and sale of whole commodity fruit and vegetable products primarily to Asia. The Biomaterials segment sells products utilizing hyaluronan, a polysaccharide that is distributed in the extracellular matrix of connective tissues in both animals and humans, and non-hyaluronan (HA) products for medical use primarily in the ophthalmic, orthopedic and other markets.

Webull offers kinds of Landec Corporation stock information, including NASDAQ:LNDC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, LNDC stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading LNDC stock methods without spending real money on the virtual paper trading platform.